ExactAntigen

SMAD4 antibody | antibody review based on formal publications
SMAD4 antibodies
This is a review about SMAD4 antibodies, based on 16 published articles using SMAD4 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited SMAD4 antibody.
Santa Cruz Biotechnology    search Santa Cruz Biotechnology SMAD4 products
wbSanta Cruz Biotechnologies anti-Smad4 antibody was used in western blot to study COLO-357 cell growth inhibition by TGF beta1. to the paper
chip, ip, wbSanta Cruz monoclonal Smad4 (B-8) and polyclonal Smad4 (G-20) antibodies were used in western blot, immunoprecipitation, and ChIP assay to study transcriptional repression of smad4. to the paper
wbSanta Cruz Biotechnology Inc antibody for Smad2/Smad3 was used in western blot to study the impaired Smad7-Smurf–mediated negative regulation of TGF-ß signaling in scleroderma fibroblasts. to the paper
chipSanta Cruz Biotechnology anti-Smad4 antibody was used in ChIP assay to study a novel upstream Nkx2-5 gene enhancer composed of highly repeated Smad and GATA binding sites in mouse P19 CL6 cells. to the paper
wbSanta Cruz Biotechnology anti-SMAD4 antibody (catalog no. sc-7966) was used in cultured human cell lines and in western blot to study the effect of gadd45β3' enhancer on SMAD3- and SMAD4-dependent transcriptional induction by transforming growth factor β. to the paper
emsa, wbSanta Cruz Biotechnology anti-Smad4 antibody was used in western blot and EMSA to study the effect of Smad3 on transforming growth factor-ß–induced alpha-smooth muscle actin expression in rat fibroblasts. to the paper
wbSanta Cruz Biotechnology anti-Smad4 (B-8) antibody was used in human pancreatic cancer cell lines PANC-1 and BxPC-3 and the osteoblastic osteosarcoma cell line MG-63 and in western blot to study the involvement of Smad proteins in the TGF-beta control of BGN and SLRP gene expression. to the paper
ip, wbSanta Cruz Biotechnology polyclonal anti-Smad4 antibody(catalog no. sc-1909) was used in western blot and immunoprecipitation to study the role for the interaction of up-regulated transcriptional repressors SnoN and Ski with Smad proteins and TGF beta in liver regeneration in mice live cells. to the paper
ipSanta Cruz Biotechnology rabbit polyclonal antibody against Smad4 was used in immunoprecipitation to examine the influence of transforming growth factor (TGF) -ß1 on proximal tubular epithelial cell-cell interaction, with particular emphasis on the regulation of adherens junction complex formation. to the paper
ihSanta Cruz Biotechnology Smads4 antibody was used in immunohistochemistry to demonstrate that alterations in the Smad pathway is responsible for TGF-beta hyperresponsiveness. to the paper
ih, wbSanta Cruz Biotechnology monoclonal mouse anti-Smad4 antibody was used in western blot and immunohistochemistry to address whether and how TGF-beta signaling becomes disrupted during human breast cancer development in vivo. to the paper
wbSanta Cruz Biotechnology antibody to Smad4 was used in western blot to detect Smad4 in human HT29 colon carcinoma sublines U9, HD3 and HD6 and human SW480 and SKCO-1 colon carcinoma cells. to the paper
Millipore    search Millipore SMAD4 products
ip, wbUpstate Biotechnology anti-Smad4/DPC4 antibody was used in western blot and immunoprecipitation to study that transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. to the paper
emsa, wbUpstate Biotechnology anti-Smad4 antibody was used in western blot and EMSA to study the inhibitory effect of TGFbeta on adipocyte differentiation through Smad3 interacting with C/EBP and Repressing C/EBP transactivation function. to the paper
wbUpstate Biotechnology polyclonal anti-Smad4 antibody(catalog no. 06-693) was used in western blot to study the role for the interaction of up-regulated transcriptional repressors SnoN and Ski with Smad proteins and TGF beta in liver regeneration in mice live cells. to the paper
ip, wbUpstate Biotechnology anti-human Smad4 antibody was used in human T47D and MCF-7 cells and in immunoprecipitation and western blot to study a signaling pathway for IGFBP-3 from a cell surface receptor to nuclear transcriptional activity. to the paper
NOVOCASTRA
ihNovocastra SMAD4 antibody was tested in immunohistochemistry by HPA (CAB002312) . to the paper
Articles Reviewed
1:Anja Persson et al. A human protein atlas based on antibody proteomics. 2006
2:Che-Chang Chang et al. Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4. 2005
3:Nichole Boyer Arnold et al. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein. 2005
4:Yoshihide Asano et al. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. 2004
5:Carl O Brown et al. The cardiac determination factor, Nkx2-5, is activated by mutual cofactors GATA-4 and Smad1/4 via a novel upstream enhancer. 2004
6:Michael B Major et al. Identification of a gadd45beta 3' enhancer that mediates SMAD3- and SMAD4-dependent transcriptional induction by transforming growth factor beta. 2004
7:Lisa Choy et al. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. 2003
8:Biao Hu et al. Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. 2003
9:Dirk Haller et al. Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. 2003
10:Marina Macias-Silva et al. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration. 2002
11:Ya Chung Tian et al. Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. 2002
12:Chunming Dong et al. Deficient Smad7 expression: a putative molecular defect in scleroderma. 2002
13:Susan Fanayan et al. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. 2002
14:Wen-Bin Chen et al. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. 2002
15:Wen Xie et al. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. 2002
16:Zhongfa Yan et al. Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1. 2002


2008©ExactAntigen home | browse | about